Vertex Pharmaceuticals
VRTX
#182
Rank
C$155.25 B
Marketcap
C$605.55
Share price
-0.01%
Change (1 day)
-9.85%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total assets

Total assets on the balance sheet as of September 2025 : C$34.45 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total assets are C$34.45 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vertex Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$32.33 B7.25%
2023-12-31C$30.14 B22.41%
2022-12-31C$24.62 B43.88%
2021-12-31C$17.11 B14.25%
2020-12-31C$14.98 B37.92%
2019-12-31C$10.86 B27.69%
2018-12-31C$8.50 B90.84%
2017-12-31C$4.45 B14.52%
2016-12-31C$3.89 B12.31%
2015-12-31C$3.46 B27.93%
2014-12-31C$2.70 B9.75%
2013-12-31C$2.46 B-10.03%
2012-12-31C$2.74 B22.37%
2011-12-31C$2.24 B30%
2010-12-31C$1.72 B-16.17%
2009-12-31C$2.05 B72.59%
2008-12-31C$1.19 B98.68%
2007-12-31C$0.60 B-44.08%
2006-12-31C$1.07 B67.87%
2005-12-31C$0.63 B-2.44%
2004-12-31C$0.65 B-30.28%
2003-12-31C$0.93 B-27.06%
2002-12-31C$1.28 B-12.58%
2001-12-31C$1.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
C$81.11 B 135.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$185.56 B 438.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$179.53 B 421.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$134.27 B 289.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$267.21 B 675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C$0.41 B-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA